These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus. Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Nakamura T; Matsubara T; Asanuma K; Komada Y; Uchida A; Sudo A Int J Oncol; 2012 Sep; 41(3):893-902. PubMed ID: 22692919 [TBL] [Abstract][Full Text] [Related]
51. Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions? Seehusen F; Orlando EA; Wewetzer K; Baumgärtner W Acta Neuropathol; 2007 Dec; 114(6):597-608. PubMed ID: 17965866 [TBL] [Abstract][Full Text] [Related]
52. Phylogenetic analysis of canine distemper viruses isolated from vaccinated dogs in Wuhan. Li W; Cai C; Xue M; Xu G; Wang X; Zhang A; Han L J Vet Med Sci; 2018 Nov; 80(11):1688-1690. PubMed ID: 30175724 [TBL] [Abstract][Full Text] [Related]
53. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138 [TBL] [Abstract][Full Text] [Related]
54. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma. Suter SE; Chein MB; von Messling V; Yip B; Cattaneo R; Vernau W; Madewell BR; London CA Clin Cancer Res; 2005 Feb; 11(4):1579-87. PubMed ID: 15746063 [TBL] [Abstract][Full Text] [Related]
55. The recombinant EHV-1 vector producing CDV hemagglutinin as potential vaccine against canine distemper. Pan Z; Liu J; Ma J; Jin Q; Yao H; Osterrieder N Microb Pathog; 2017 Oct; 111():388-394. PubMed ID: 28888886 [TBL] [Abstract][Full Text] [Related]
56. Canine distemper virus infection of canine footpad epidermis. Gröne A; Doherr MG; Zurbriggen A Vet Dermatol; 2004 Jun; 15(3):159-67. PubMed ID: 15214952 [TBL] [Abstract][Full Text] [Related]
57. Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. Patil SS; Gentschev I; Nolte I; Ogilvie G; Szalay AA J Transl Med; 2012 Jan; 10():3. PubMed ID: 22216938 [TBL] [Abstract][Full Text] [Related]
58. Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry. Sawatsky B; Cattaneo R; von Messling V J Virol; 2018 Aug; 92(15):. PubMed ID: 29793948 [TBL] [Abstract][Full Text] [Related]
59. Variable transcription of pro- and anti-inflammatory cytokines in phocine lymphocytes following canine distemper virus infection. Seibel H; Siebert U; Rosenberger T; Baumgärtner W Vet Immunol Immunopathol; 2014 Oct; 161(3-4):170-83. PubMed ID: 25190509 [TBL] [Abstract][Full Text] [Related]